id-logo-symbol

Today’s Infectious Disease News (7/25/20)

COVID-19 Vaccine Enters Phase III Trial

NIAID and Moderna announced that their jointly developed experimental vaccine officially began its much-anticipated phase III clinical trial. The potential vaccine is the first in the United States to enter a large-scale trial. This phase of testing will include 30,000 adults. In order to demonstrate its effectiveness, the vaccine will have to provide protection for 60% of study participants. The public-private partnership between the US government and Moderna aims to produce “hundreds of millions” of doses by early next year.

Full Story: Science Speaks

Skip to content